Rafeeq Habeeb

FDA investigator

Appears on 20 documents from 2020 to 2026, most often at sites in India. Most often cites production record review (21 CFR 211.192).

20
Documents on file
6.5
Observations per 483
2020
First seen
2026
Most recent

What they cite most

From 129 observations

Activity by year

2020: 1, 2021: 3, 2022: 3, 2023: 5, 2024: 1, 2025: 6, 2026: 1

Where

India 8 · Indiana 3 · Ohio 3 · Mexico 2 · Utah 2 · Canada 1

Is Rafeeq Habeeb coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

20 documents, newest first
FirmOpen
483 Dabur India LimitedJan 16, 2026 · Dadra And Nagar Haveli, India
483 APL HEALTHCARE LIMITEDDec 17, 2025 · Menakuru, India
483 LUPIN LIMITEDJul 17, 2025 · Pithampur, India
483 Lupin LimitedJul 17, 2025 · Pithampur, India
483 Lupin LimitedJul 8, 2025 · Pithampur, India
483 KUTOL PRODUCTS COMPANYMar 4, 2025 · SHARONVILLE, Ohio
483 Resilience US, LLCJan 21, 2025 · West Chester, Ohio

About this profile

What does Rafeeq Habeeb inspect?

Rafeeq Habeeb appears on 20 documents on file covering 19 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.194(a) and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rafeeq Habeeb is dated Jan 16, 2026.